Actidose-Aqua Advance (2010)
Βιβλιογραφική αναφορά
Στοιχεία εκδότη
| Εκδότης | Alliance Pharmaceuticals |
|---|---|
| Διεύθυνση | Avonbridge House, Bath Road, Chippenham, Wiltshire, SN15 2BB |
Για την προβολή της πλήρους καταχώρησης απαιτείται συνδρομή σε ισχύ.
Αποκτήστε πρόσβαση σε όλες τις πληροφορίες και τα εργαλεία του Galinos.gr δωρεάν για έναν μήνα απλά κάνοντας εγγραφή.
Δωρεάν εγγραφή
Αποκτήστε πρόσβαση σε όλες τις πληροφορίες και τα εργαλεία του Galinos.gr δωρεάν για έναν μήνα απλά κάνοντας εγγραφή.
Δωρεάν εγγραφή
Name of the medicinal product
Actidose-Aqua Advance.
Qualitative and quantitative composition
Actidose-Aqua Advance contains 1.04 g of Activated Charcoal/5 ml.
Pharmaceutical form
Suspension for oral administration.
Therapeutic indications
For the emergency treatment of acute poisoning and drug overdosage where substances such as those listed in section 5.1 have been ingested. The list is not exhaustive and Actidose-Aqua Advance may be of ...
Posology and method of administration
The container should be shaken thoroughly prior to administration. If the dose of poison that has been ingested is known, a ratio of 10:1 (activated charcoal:toxin) may be used to determine the optimal ...
Contraindications
Use of Actidose-Aqua Advance is contra-indicated in persons who are not fully conscious.
Special warnings and precautions for use
Actidose-Aqua Advance is not recommended for patients who have ingested corrosive agents such as strong acids or alkalis since the activated charcoal may obscure endoscopic visualisation of oesophageal ...
Interaction with other medicinal products and other forms of interaction
Actidose-Aqua Advance will adsorb most medicaments and many other chemical substances. If a specific antidote is to be administered the likelihood of its adsorption by activated charcoal should be borne ...
Fertility, pregnancy and lactation
The safety of this medicinal product for use in human pregnancy has not been established. Experimental animal studies are insufficient to assess the safety with respect to the development of the embryo ...
Effects on ability to drive and use machines
None known.
Undesirable effects
Both the patient and health care professionals should be aware that Actidose-Aqua Advance will produce black stools. A laxative may be given concurrently to accelerate the removal of the activated charcoal-toxin ...
Overdose
Actidose-Aqua Advance is well tolerated and due to its lack of toxicity overdosage requiring treatment is unlikely. A laxative may be administered to enhance elimination of the product.
Pharmacodynamic properties
Activated charcoal has a high adsorptive capacity for a wide range of compounds including many of those which are most commonly encountered in deliberate and accidental poisoning. Substances adsorbed include ...
Pharmacokinetic properties
Activated charcoal is not absorbed from the gastrointestinal tract or subject to any metabolic processes. It is eliminated in the faeces.
Preclinical safety data
Activated charcoal is essentially inert pharmacologically and it would therefore be expected to be virtually devoid of toxicity, other than any ill effects arising from mechanical obstruction of the gut, ...
List of excipients
Sucrose Propylene glycol Glycerine Citric Acid Purified water
Incompatibilities
None known.
Shelf life
Two years.
Special precautions for storage
Store at 15 30°C. Do not refrigerate.
Nature and contents of container
Low density polyethylene bottles containing 120 ml. Low density polyethylene bottles containing 240 ml. Low density polyethylene tubes containing 120 ml.
Special precautions for disposal and other handling
Shake well before use.
Marketing authorization holder
Alliance Pharmaceuticals Ltd Avonbridge House 2 Bath Road Chippenham Wiltshire SN15 2BB UK
Marketing authorization number(s)
PL 16853/0119
Date of first authorization / renewal of the authorization
26 March 1996
Date of revision of the text
14th July 2010